Sex Differences in Computed Tomography Coronary Stenosis Severity Versus Flow Impairment and Impact on

Lavinia Gabara1,2, Jonathan Hinton1,2, Mohamed Kira1,2

  • 1Coronary Research Group University Hospital Southampton NHS FT Southampton United Kingdom.

Insights

Women with coronary artery disease show less flow impairment despite similar stenosis severity, leading to different management and lower costs. Sex did not predict major adverse cardiovascular events in this study.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Health Economics

Background:

  • Sex-based differences in coronary artery disease (CAD) presentation and outcomes are not fully understood.
  • The interplay between coronary atheroma, flow impairment, and clinical impact by sex requires further investigation.

Purpose of the Study:

  • To investigate sex differences in coronary stenosis severity and flow impairment using coronary computed tomography angiography (CCTA) and fractional flow reserve derived from computed tomography (FFRCT).
  • To assess the association of these findings with revascularization, healthcare costs, and adverse clinical events in patients with stable CAD.

Main Methods:

  • Secondary analysis of the FORECAST trial involving 212 patients (32.1% female) with stable CAD.
  • Coronary computed tomography angiography (CCTA) and FFRCT were used to assess stenosis severity and flow impairment.
  • Outcomes including revascularization, resource usage, and major adverse cardiovascular events were evaluated at 9-month follow-up.

Main Results:

  • No significant sex difference in significant coronary artery disease prevalence (38.2% women vs. 51.3% men).
  • Female participants exhibited significantly less coronary flow impairment (FFRCT ≤0.8: 47.0% vs. 71.5%).
  • Women underwent fewer revascularization procedures and incurred lower healthcare costs compared to men.

Conclusions:

  • Significant sex differences exist in the anatomico-functional assessment of coronary artery disease.
  • These differences influence clinical management, healthcare costs, and adverse event rates.
  • While sex differences impact management and costs, FFRCT and stenosis severity independently predict adverse events.
Abstract